Literature DB >> 30444175

Matrix Metalloproteinase 9 and Osteopontin Interact to Support Synaptogenesis in the Olfactory Bulb after Mild Traumatic Brain Injury.

Melissa A Powell1, Raiford T Black1, Terry L Smith1, Thomas M Reeves1, Linda L Phillips1.   

Abstract

Olfactory receptor axons reinnervate the olfactory bulb (OB) after chemical or transection lesion. Diffuse brain injury damages the same axons, but the time course and regulators of OB reinnervation are unknown. Gelatinases (matrix metalloproteinase [MMP]2, MMP9) and their substrate osteopontin (OPN) are candidate mediators of synaptogenesis after central nervous system (CNS) insult, including olfactory axon damage. Here, we examined the time course of MMP9, OPN, and OPN receptor CD44 response to diffuse OB injury. FVBV/NJ mice received mild midline fluid percussion insult (mFPI), after which MMP9 activity and both OPN and CD44 protein expression were measured. Diffuse mFPI induced time-dependent increase in OB MMP9 activity and elevated the cell signaling 48-kD OPN fragment. This response was bimodal at 1 and 7 days post-injury. MMP9 activity was also correlated with 7-day reduction in a second 32-kD OPN peptide. CD44 increase peaked at 3 days, delayed relative to MMP9/OPN response. MMP9 and OPN immunohistochemistry suggested that deafferented tufted and mitral neurons were the principal sites for these molecular interactions. Analysis of injured MMP9 knockout (KO) mice showed that 48-kD OPN production was dependent on OB MMP9 activity, but with no KO effect on CD44 induction. Olfactory marker protein (OMP), used to identify injured olfactory axons, revealed persistent axon damage in the absence of MMP9. MMP9 KO ultrastructure at 21 days post-injury indicated that persistent OMP reduction was paired with delayed removal of degenerated axons. These results provide evidence that diffuse, concussive brain trauma induces a post-injury interaction between MMP9, OPN, and CD44, which mediates synaptic plasticity and reinnervation within the OB.

Entities:  

Keywords:  metalloproteinase; olfactory bulb; osteopontin; synaptogenesis

Mesh:

Substances:

Year:  2019        PMID: 30444175      PMCID: PMC6531908          DOI: 10.1089/neu.2018.5994

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  101 in total

Review 1.  Heparan sulfate proteoglycans in the nervous system: their diverse roles in neurogenesis, axon guidance, and synaptogenesis.

Authors:  Y Yamaguchi
Journal:  Semin Cell Dev Biol       Date:  2001-04       Impact factor: 7.727

2.  Regulation of the cell adhesion molecule CD44 after nerve transection and direct trauma to the mouse brain.

Authors:  L L Jones; Z Liu; J Shen; A Werner; G W Kreutzberg; G Raivich
Journal:  J Comp Neurol       Date:  2000-10-23       Impact factor: 3.215

3.  Recovery of structure and function following transection of the primary olfactory nerves in pigeons.

Authors:  N Oley; R S DeHan; D Tucker; J C Smith; P P Graziadei
Journal:  J Comp Physiol Psychol       Date:  1975-02

4.  Metalloproteinase increases in the injured rat spinal cord.

Authors:  R C de Castro; C L Burns; D J McAdoo; A M Romanic
Journal:  Neuroreport       Date:  2000-11-09       Impact factor: 1.837

5.  Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury.

Authors:  X Wang; J Jung; M Asahi; W Chwang; L Russo; M A Moskowitz; C E Dixon; M E Fini; E H Lo
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

6.  Expression of osteopontin mRNA in the adult rat brain.

Authors:  S L Shin; J H Cha; M H Chun; J W Chung; M Y Lee
Journal:  Neurosci Lett       Date:  1999-10-01       Impact factor: 3.046

7.  Compartmental organization of the olfactory bulb glomerulus.

Authors:  H J Kasowski; H Kim; C A Greer
Journal:  J Comp Neurol       Date:  1999-05-03       Impact factor: 3.215

8.  Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin).

Authors:  R Agnihotri; H C Crawford; H Haro; L M Matrisian; M C Havrda; L Liaw
Journal:  J Biol Chem       Date:  2001-05-25       Impact factor: 5.157

9.  Pattern of olfactory bulb innervation returns after recovery from reversible peripheral deafferentation.

Authors:  D M Cummings; D K Emge; S L Small; F L Margolis
Journal:  J Comp Neurol       Date:  2000-06-05       Impact factor: 3.215

10.  Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway.

Authors:  I Okamoto; Y Kawano; D Murakami; T Sasayama; N Araki; T Miki; A J Wong; H Saya
Journal:  J Cell Biol       Date:  2001-11-19       Impact factor: 10.539

View more
  5 in total

1.  Dexmedetomidine alleviates olfactory cognitive dysfunction by promoting neurogenesis in the subventricular zone of hypoxic-ischemic neonatal rats.

Authors:  Andi Chen; Xiaohui Chen; Jianhui Deng; Jianjie Wei; Haitao Qian; Yongxin Huang; Shuyan Wu; Fei Gao; Cansheng Gong; Yanling Liao; Xiaochun Zheng
Journal:  Front Pharmacol       Date:  2022-08-19       Impact factor: 5.988

2.  Quantitative Proteomics Reveals the Dynamic Pathophysiology Across Different Stages in a Rat Model of Severe Traumatic Brain Injury.

Authors:  Weikang Luo; Zhaoyu Yang; Wei Zhang; Dan Zhou; Xiaohang Guo; Shunshun Wang; Feng He; Yang Wang
Journal:  Front Mol Neurosci       Date:  2022-01-25       Impact factor: 5.639

3.  Potential Progression Mechanism and Key Genes in Early Stage of mTBI.

Authors:  Hu Zhou; Xue Han; Hui-Xia Zhou; Zhen-Zhen Cao; Li Yang; Jian-Yun Yu
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-03       Impact factor: 2.650

4.  Metabolic dyshomeostasis induced by SARS-CoV-2 structural proteins reveals immunological insights into viral olfactory interactions.

Authors:  Mercedes Lachén-Montes; Naroa Mendizuri; Karina Ausín; Miriam Echaide; Ester Blanco; Luisa Chocarro; María de Toro; David Escors; Joaquín Fernández-Irigoyen; Grazyna Kochan; Enrique Santamaría
Journal:  Front Immunol       Date:  2022-09-08       Impact factor: 8.786

Review 5.  Osteopontin as a candidate of therapeutic application for the acute brain injury.

Authors:  Yunxiang Zhou; Yihan Yao; Lesang Sheng; Jianmin Zhang; John H Zhang; Anwen Shao
Journal:  J Cell Mol Med       Date:  2020-07-13       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.